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The diaphragm is the primary inspiratory pump muscle of breathing. Notwithstanding
its critical role in pulmonary ventilation, the diaphragm like other striated muscles is
malleable in response to physiological and pathophysiological stressors, with potential
implications for the maintenance of respiratory homeostasis. This review considers
hypoxic adaptation of the diaphragm muscle, with a focus on functional, structural, and
metabolic remodeling relevant to conditions such as high altitude and chronic respiratory
disease. On the basis of emerging data in animal models, we posit that hypoxia is
a significant driver of respiratory muscle plasticity, with evidence suggestive of both
compensatory and deleterious adaptations in conditions of sustained exposure to low
oxygen. Cellular strategies driving diaphragm remodeling during exposure to sustained
hypoxia appear to confer hypoxic tolerance at the expense of peak force-generating
capacity, a key functional parameter that correlates with patient morbidity and mortality.
Changes include, but are not limited to: redox-dependent activation of hypoxia-inducible
factor (HIF) and MAP kinases; time-dependent carbonylation of key metabolic and
functional proteins; decreased mitochondrial respiration; activation of atrophic signaling
and increased proteolysis; and altered functional performance. Diaphragm muscle
weakness may be a signature effect of sustained hypoxic exposure. We discuss the
putative role of reactive oxygen species as mediators of both advantageous and
disadvantageous adaptations of diaphragm muscle to sustained hypoxia, and the role of
antioxidants in mitigating adverse effects of chronic hypoxic stress on respiratory muscle
function.
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BREATHING LIFE INTO A HYPOTHESIS: HYPOXIA IS AN
INDEPENDENT CONTRIBUTOR TO DIAPHRAGM MUSCLE
DYSFUNCTION IN CHRONIC RESPIRATORY DISEASE
The diaphragm is the primary inspiratory pump muscle critical for pulmonary ventilation. Force
and power generation as well as fatigue resistance are important functional parameters given the
distinctive function of the muscle, with a requirement for continuous rhythmic activity throughout
life, and the requirement to produce more powerful contractions during conditions of increased
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respiratory drive and loaded conditions such as airway narrowing
and airway clearance maneuvres. The diaphragm is unique
among skeletal muscles given its vital physiological role, yet
as a skeletal muscle it is nonetheless extremely malleable
in response to physiological and pathophysiological stressors
(Polla et al., 2004). Whilst this inherent plasticity affords great
flexibility in a dynamic control system such as breathing,
conferring a capacity for altered structure-function relationships
in response to physiological challenges (e.g., development,
exercise, environmental challenges etc.), it too poses a significant
challenge for the maintenance of respiratory homeostasis in
response to pathophysiological stressors (e.g., cancer cachexia,
mechanical ventilation-induced atrophy, and respiratory diseases
such as chronic obstructive pulmonary disease (COPD) etc.).
One such physiological stressor, a condition of inadequate
O2 delivery to cells and tissues such that metabolic demands
are not appropriately met (or impaired utilization of O2 by
cells), namely hypoxia, is a facet of several chronic respiratory
diseases, which promotes muscle weakness and deterioration
(Shiota et al., 2004; Degens et al., 2010; McMorrow et al., 2011;
Lewis et al., 2016). Acute bouts of hypoxia typically provide,
in conjunction with a mechanical stimulus, a signal to drive
exercise-induced adaptations in skeletal muscles (Desplanches
et al., 1993; Hoppeler and Vogt, 2001; Mason et al., 2007; Rasbach
et al., 2010; Lindholm and Rundqvist, 2016). It is recognized
that PaO2 in COPD patients can drop below 60 mmHg (Anon,
1980; Ribera et al., 2003), yet surprisingly there is generally little
known about the effects of sustained hypoxia on diaphragm
function in the context of COPD, largely owing to the numerous
co-existing contributors to respiratory muscle morbidity in the
disease. Similarly, there is little attention paid to the potentially
deleterious effects of hypoxia on diaphragm function at altitude.
On the basis of emerging data in animal models, we raise the
possibility that hypoxia is a significant driver of respiratory
muscle plasticity in conditions of sustained exposure to low
oxygen.
The diaphragm has a considerable functional reserve capacity
which can be readily observed through reflex hyperventilation in
response to hypoxic insult in order to limit oxygen desaturation
in arterial blood, and especially duringmaximal activation during
airway blockage or reflex behaviors such as cough and sneeze
(Brown et al., 2014; Greising et al., 2016). Sustained hypoxia
weakens the diaphragm (Shiota et al., 2004; Degens et al.,
2010; McMorrow et al., 2011; Lewis et al., 2016), potentially
priming an inability to cope with further increases in workload
as may occur in exacerbations of chronic respiratory diseases,
contributing to disease progression. Indeed, in COPD patients,
maximum inspiratory pressure correlates with survival (Bégin
and Grassino, 1991; Gray-Donald et al., 1996; Zielinski et al.,
1997), and following inspiratory loading, the COPD diaphragm
is more susceptible to injury (Orozco-Levi et al., 2001).
This review discusses the literature as it pertains to
sustained hypoxia-induced functional, structural, and metabolic
remodeling of the diaphragm muscle in animal models, drawing
attention to hypoxia as a potential mediator of diaphragm
dysfunction in human conditions associated with sustained
hypoxia, such as high altitude and respiratory diseases. For
comprehensive literature reviews and research regarding muscle
remodeling and oxidative stress in COPD and high altitude
specifically, we refer the reader to excellent work by other
authors (Hoppeler et al., 2003; Raguso et al., 2004; Barreiro
et al., 2005; Wijnhoven et al., 2006a; Ottenheijm et al., 2008;
Murray, 2009). The role of reactive oxygen species (ROS) as the
putative candidates driving both compensatory (advantageous)
and deleterious (disadvantageous) (mal) adaptations to sustained
hypoxia is considered. We also briefly discuss the potential
application of antioxidants as adjunctive treatments. An
understanding of the physiological and pathophysiological
mechanisms underpinning diaphragm (mal) adaptation to
sustained hypoxia at molecular, cellular, tissue and integrative
system levels is of relevance to clinical medicine and high altitude
adventure and should help to inform therapeutic strategies to
combat respiratory muscle dysfunction.
SUSTAINED HYPOXIA: WILL THE PRIMARY
STIMULUS PLEASE STEP FORWARD?
To elucidate the cellular processes driving sustained hypoxia-
induced diaphragm (mal) adaptation we must first consider the
primary stimuli that initiate signaling cascades and adaptive
events. Hypoxia (decreased cellular PO2) per se will result in
hypoxia inducible factor (HIF) stabilization (Stroka et al., 2001)
and subsequent transcriptional events; the oxygen deficit will also
register in cell mitochondria where O2 is the ultimate electron
acceptor in the electron transport chain, required for oxidative
ATP production (Chandel et al., 1998; Schumacker, 2002; Waypa
and Schumacker, 2006; Gamboa and Andrade, 2010, 2012).
Hypoxia at the mitochondrial level will result in electron build-
up in the electron transport chain, subsequent electron leak, and
formation of ROS (Schumacker, 2002; Waypa and Schumacker,
2006). Reflex hyperventilation in response to hypoxia, which
improves oxygen delivery to the pulmonary tissues, can be
considered, in the context of respiratory muscle recruitment,
an endurance training-like stimulus. In addition, acid-base
disturbances secondary to hyperventilation are relevant in early
time domains of hypoxic exposure until renal compensatory
mechanisms correct hypoxia-induced alkalosis of the blood.
Moreover, hypometabolic strategies in small rodents, particularly
mice during hypoxic exposure are also relevant to the discussion,
especially since such effects may differ between mouse and
man. Thus, there are complex and often competing stimuli
in respiratory muscles during exposure to sustained hypoxia.
For example, chronic increased sub-maximal activity of the
diaphragm in sustained hypoxia might be expected to elicit an
increased capacity for oxidative metabolism (Gollnick et al.,
1973; Thomas and Marshall, 1997) with implications for muscle
endurance, whereas hypoxia and HIF1-α have been shown to
promote a glycolytic phenotype (Semenza et al., 1994), which in-
and-of itself should decrease endurance. Furthermore, persistent
hypoxia and increased muscle activity are sustained stimuli
but with changing intensities over time, therefore a dynamic
temporal component or signature will also be relevant in
sustained hypoxia-induced diaphragm remodeling (Lewis et al.,
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2016). This complexity increases further in disease states such
that evaluating the contribution of a stimulus in isolation is a
difficult task.
MAY THE FORCE BE WITH YOU:
FUNCTIONAL CHANGES IN THE
DIAPHRAGM MUSCLE FOLLOWING
SUSTAINED HYPOXIA
In this section we compare and contrast reported data for
functional measurements of the diaphragm muscle obtained
from animal models of chronic hypoxia. The functional
performance of the diaphragm as the primary respiratory pump
muscle is of utmost physiological importance in terms of
breathing.
Rodent diaphragm muscle twitch contractile kinetics
measured ex vivo are unchanged following 6 weeks of exposure
to sustained hypoxia (El-Khoury et al., 2003; Shiota et al., 2004;
McMorrow et al., 2011; Lewis et al., 2016), suggestive of little
or no change in Ca2+ release/re-uptake from the sarcoplasmic
reticulum. Rodent diaphragm peak specific force is decreased at
30◦C, 35◦C, and 37◦C following 6 weeks of sustained hypoxia
(Shiota et al., 2004; McMorrow et al., 2011; Lewis et al., 2016),
but no change is observed at 25◦C (El-Khoury et al., 2003).
Peak work and power are similarly affected, without effects
on peak shortening and peak shortening velocity (Lewis et al.,
2016). Thus, it appears that decreased force-generating capacity
is the signature response to sustained hypoxia, contributing
to decreases in isotonic work and power. Peak tetanic force is
decreased ∼30% in rat (McMorrow et al., 2011) and mouse
(Lewis et al., 2016) diaphragm following 6 weeks of sustained
hypoxia. Maintained or improved fatigue tolerance (suggestive
of increased aerobic capacity) is reported in rodent diaphragm
after 4 and 6 weeks of sustained hypoxia (El-Khoury et al.,
2003; Shiota et al., 2004; McMorrow et al., 2011; Gamboa and
Andrade, 2012), although a decrease in endurance was observed
in mouse diaphragm after 6 weeks of sustained hypoxia (Lewis
et al., 2016). Single fiber studies of diaphragm muscle from
rats exposed to sustained hypoxia for a duration of 4 weeks
reveal significant reductions in force production by type I and
type II fibers, with the type II fibers apparently more severely
affected (Degens et al., 2010), a finding consistent with hypoxia-
dependent diaphragm weakness. Consistent with observations
in tissue bundle preparations (Lewis et al., 2016), no changes
were observed in diaphragm single fiber shortening velocities,
but power production was significantly decreased (Degens
et al., 2010). Although weaker under “control” experimental
conditions, it is reported that respiratory muscle from animals
exposed to sustained hypoxia performs better in terms of fatigue
tolerance in acute severe hypoxic conditions compared with
muscles from normoxic control animals (Lewis et al., 2015a)
i.e., there is hypoxic tolerance following exposure to sustained
hypoxia. Thus, reprogramming and remodeling would appear
advantageous to survival and tolerance of the chronic stressor,
but with resultant deleterious consequences for physiological
function under some conditions. Diaphragm muscle is generally
resilient compared with limb muscle (Faucher et al., 2005;
El-Khoury et al., 2012), but nevertheless shows evidence of
altered functional performance (McMorrow et al., 2011; Gamboa
and Andrade, 2012; Lewis et al., 2016). Sustained hypoxia-
induced functional adaptations in the diaphragm appear to
maintain or improve performance in severe hypoxic conditions
(Gamboa and Andrade, 2012). Whereas, improved fatigue
resistance likely facilitates increased contractile activity during
hypoxic exposure (hyperventilation), force-generating capacity,
and consequently power generation in the diaphragm can be
compromised following sustained hypoxia and this potentially
contributes to poor clinical outcomes in the chronic diseased
state (if similar changes occur in humans), particularly likely with
added stressors such as increased respiratory load, altered chest
mechanics, and respiratory disease exacerbations. Diaphragm
strength correlates with patient morbidity and mortality, at
least in the critical care setting (Supinski and Callahan, 2013).
Therefore, on balance, we conclude that functional changes
in the diaphragm muscle exposed to sustained hypoxia confer
some protection from severe hypoxic stress but with an apparent
functional trade-off, namely compromised force-generating
capacity, which may have deleterious consequences for
respiratory homeostasis during disease progression (Ottenheijm
et al., 2005, 2007) or during protracted sojourns at high altitude
(Gudjonsdottir et al., 2001; Zhu et al., 2005; Ottenheijm et al.,
2006a; Verges et al., 2010).
FORM BEGETS FUNCTION: STRUCTURAL
CHANGES IN THE DIAPHRAGM MUSCLE
FOLLOWING SUSTAINED HYPOXIA
Skeletal muscles are heterogeneous in terms of muscle fiber type
size, and proportion, and the complement of ATP-producing
mitochondria, which combine to facilitate the particular function
of a muscle. Furthermore, muscle retains a capacity for
considerable remodeling in response to stimuli; protein turnover
is relatively high in this active tissue type. The diaphragmmuscle,
albeit unique, is no exception. Structure of skeletal muscle is an
important determinant of muscle function.
Fiber type proportions are unaffected in diaphragm muscle
after 6 weeks of sustained hypoxia in animal models (Deveci
et al., 2001; Shiota et al., 2004; McMorrow et al., 2011). Even
from birth, when muscle plasticity is greatest, muscle fiber types
remained unaltered in rat diaphragm after exposure to sustained
hypoxia during different developmental windows (Carberry
et al., 2014). Sustained hypoxia alone is thus likely insufficient
to drive the muscle fiber type changes that are observed in the
COPD diaphragm (Levine et al., 1997; Barreiro et al., 2005).
Decreased muscle fiber cross-sectional areas are observed in the
diaphragm muscle of animal models of sustained hypoxia, whilst
no significant changes to numerical, or areal fiber densities have
been reported (McMorrow et al., 2011; Gamboa and Andrade,
2012). Hypoxic-dependent decreases in fiber cross-sectional area
might be expected to produce atrophy in the non-working
limb muscles compared with the working respiratory muscles
in sustained hypoxia. Of course, decreased fiber areas result in
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reduced O2 diffusion distances, but likely contribute to decreased
force-generating capacity, should myofibrils also decrease.
Four weeks of sustained hypoxia increased the activity of
the mito-phagocytic protein BNIP-3 and decreased PGC-1α
and PPARγ resulting in decreased mitochondrial density and
associated proteins in mouse diaphragm (Gamboa and Andrade,
2010).Mitochondrial morphological changes are also observed in
rat and human skeletal muscles exposed to hypoxia (Amicarelli
et al., 1999; Hoppeler et al., 2003; Magalhães et al., 2005). These
adaptations will decrease oxygen consumption by mitochondria
in myocytes and decrease ROS formation although hypoxia-
induced ROS may be the cause of mitochondrial morphological
changes and degradation. Indeed, increased activity of the ROS-
sensitive chymotrypsin-like activity of the 20S proteasome is also
observed after 6 weeks of sustained hypoxia in mouse diaphragm
muscle (Lewis et al., 2016) with the proteasome representing a
therapeutic target for COPD (Ottenheijm et al., 2006b; van Hees
et al., 2011).
Whilst sustained hypoxia reduces muscle fiber cross-sectional
area and mitochondrial density, and auto-phagocytic proteins
are up-regulated (Zhu et al., 2003; Gamboa and Andrade,
2010; McMorrow et al., 2011; Lewis et al., 2016), it is unclear
if diaphragm muscle mass is reduced in the hypoxic mouse
diaphragm muscle (as it does in the COPD diaphragm; Doucet
et al., 2010; Testelmans et al., 2010), since changes could
relate to altered protein synthesis without an overall change to
muscle mass. However, bi-phasic changes in signaling proteins
regulating muscle size and increased proteasome activity suggest
prolonged exposure to sustained hypoxia results in atrophy
(Lewis et al., 2016), similar to COPD (Ottenheijm et al., 2006b;
van Hees et al., 2007). Whilst 1 week of sustained hypoxia
increases phospho-FOXO3a and phospho-mTOR content in
mouse diaphragm muscle, 6 weeks of exposure decreases
phospho-FOXO3a, phospho-mTOR and increases phospho-
p38MAPK content (Lewis et al., 2016), effectively placing a brake
on protein translation and allowing up-regulation of pro-atrophy
genes. Of interest, antioxidants attenuate increased phospho-
p38 MAPK content whilst phospho-AKT content, an upstream
regulator of FOXO3a and mTOR in response to humoral factors,
does not significantly change in hypoxia (Lewis et al., 2016).
This is further suggestive of ROS being pivotal to promoting the
observed hypoxia-induced structural changes inmuscle (Zuo and
Clanton, 2005).
Whilst decreased muscle size reduces O2 diffusion distances
and decreased mitochondrial density maintains sufficient
oxygen for the remaining mitochondrial population, which
are presumably advantageous outcomes, autophagic processes
could adversely affect ATP production and subsequently muscle
function, or even muscle function directly at the level of the
cross-bridge, which could explain functional outcomes such
as weakness following exposure to sustained hypoxia. Most
commentators focus on structural (and molecular) changes that
are consistent with functional measures from a perspective that
the former cause the latter. In integrative settings, however, it
is entirely plausible that functional adjustments impose new
additional stressors that could serve to shape molecular and
cellular changes, which on the face of it might even appear
contradictory to the functional measure, especially if, for
example, such changes are compensatory—that is, caused
by dysfunction as opposed to causing it. This complicates
interpretation of structure-function inter-relationships in
hypoxic (and by extension diseased) muscle.
A PROGRAMME CHANGE IN THE FACE OF
STRESS: METABOLIC CHANGES IN THE
DIAPHRAGM MUSCLE FOLLOWING
SUSTAINED HYPOXIA
ATP is required for muscle contraction and homeostasis; the
main sources of ATP are the phosphocreatine system, glycolysis,
and oxidative phosphorylation in the mitochondria. One might
expect tighter regulation and constraints on ATP production and
ATP usage in a hypoxic environment. ATP production pathways
and the major cellular players in ATP usage are discussed in this
section.
Assessment of mitochondrial respiration after 4 weeks of
sustained hypoxia suggests maintained mitochondrial integrity
in mouse diaphragm muscle, although state 3 respiration and
O2 consumption is reportedly lower, with no change in the
respiratory-control-ratio or uncoupled respiration (Gamboa and
Andrade, 2012). Four weeks of sustained hypoxia also decreased
uncoupling protein (UCP)3 content in mouse diaphragm
muscle (Gamboa and Andrade, 2010). A likely consequence
of decreased UCP3 content is a reduction in thermogenesis
and optimisation of O2 consumption by way of a decreased
dissipation of the proton gradient (Lewis, 2014). Of course,
decreased mitochondrial density may be detrimental because
oxidative phosphorylation in remaining mitochondria would be
maintained at the expense of altered ADP/ATP and NADH/NAD
ratio. Diaphragm muscle mitochondria appear distressed in
times of sustained hypoxia (Lewis, 2014) albeit still functional (an
example of positive and negative adaptations at the sub-cellular
level).
Six weeks of sustained hypoxia has no effect on succinate
dehydrogenase (SDH) or nicotinamide adenine dinucleotide
phosphate reduced form (NADPH)-diaphorase enzyme activity
in rat diaphragm muscle (McMorrow et al., 2011; Lewis
et al., 2015a). We speculate that adaptations in metabolism
and ATP production may occur non-uniformly, and as such
can remain hidden in global tissue (homogenate) or tissue
slice measurements. No change is observed despite decreased
fiber areas of the slow oxidative fiber types in this model
(McMorrow et al., 2011; Lewis et al., 2015a). This suggests
that mitochondria are also decreasing proportionally with fiber
size, yet fatigue tolerance is increased, suggesting increased
aerobic efficiency. A reduction in mitochondrial content in the
diaphragm has also been observed in mice after 4 weeks of
sustained hypoxia (Gamboa and Andrade, 2010). Aldolase (a
glycolysis enzyme), aconitase (a TCA cycle enzyme), and creatine
kinase (a phosphagen system enzyme) all present with decreased
activities in mouse diaphragm after 6 weeks of sustained hypoxia
(Lewis et al., 2016), suggesting that the diaphragm adopts a
hypometabolic strategy in this model. This is not uncommon
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in other mammalian hypoxia-tolerant tissues as is observed
in diving, burrowing, hibernating, and high altitude mammals
(Scholander et al., 1942; Hill et al., 1987; Hochachka et al., 1998;
MacDonald and Storey, 1999; Boutilier, 2001; Ramirez et al.,
2007; Storey and Storey, 2010).
With loss of activity, aconitase has been observed to take
on a regulatory role in transcription of proteins involved in
iron uptake, storage, and utilization in the cell nucleus (Castro
et al., 1998), as well as stabilizing mitochondrial DNA (Chen
et al., 2005). Aldolase is a HIF-responsive enzyme, although
HIF alone is not enough to drive transcription (Semenza et al.,
1996). Creatine kinase is an enzyme that co-localizes with the
cross-bridge. Interestingly, mice deficient in creatine kinase
lack the capacity for muscle burst activity, with evidence for
graded deficiencies resulting in graded burst reductions (van
Deursen et al., 1993, 1994). The deficiency in burst capacity
is likely due to insufficient generation of a bulk volume of
ATP in proximity to the cross-bridge required for widespread
and strong contractions. For the diaphragm muscle this may
be required to quickly overcome/prevent periods of airflow
limitation and may be compromised in chronic respiratory
disease (Gehlert et al., 2015); thus decreased creatine kinase
activity following sustained hypoxia (Lewis et al., 2016) is
potentially very detrimental to diaphragm function. Glucose-
6-phosphate dehydrogenase (G6PD) and lactate dehydrogenase
(LDH) are key enzymes of metabolism positioned at pivotal
substrate flux gating points; both enzymes are significantly
decreased after 3 and 6 weeks of sustained hypoxia in the mouse
diaphragm muscle (Lewis et al., 2016). Perhaps the physiological
significance of this is a more focused, albeit decreased, substrate
flux into mitochondria, and is preventative of loss of substrate
into other pathways; this however is speculative. Increased
activity of glycerol-3-phosphate dehydrogenase (G3PD, another
enzyme located at a key metabolic junction) after one, three,
and 6 weeks of sustained hypoxia, co-incident with enhanced
catalase activity in mouse diaphragm muscle (Lewis et al., 2016),
is suggestive of increased utilization of fatty acids as metabolic
substrate. Of interest, the high altitude pika diaphragm is more
dependent on β-oxidation than the diaphragm from sea-level
pika (Sheafor, 2003). β-oxidation enzyme activity correlates
with COPD severity (Wijnhoven et al., 2006b). Increased
G3PD activity likely impacts the glycerol-3-phosphate shuttle,
which may be functionally relevant given that mice lacking
G3PD are unable to maintain normal levels of ATP during
exercise (MacDonald and Marshall, 2000); thus increased G3PD
activity is potentially very beneficial to diaphragm function
during hypoxic stress. The activity of GAPDH is increased
in the mouse diaphragm muscle after 1 week of sustained
hypoxia, but decreased after 3 weeks of exposure to sustained
hypoxia (Lewis et al., 2016). This reveals an early glycolytic
shift in the diaphragm, beneficial to function in times of low
oxygen availability (especially short powerful contractions whose
importance in diseased states has been highlighted), but this
becomes negated temporally, due to cumulative time-dependent
redox stress (protein oxidation) (Lewis et al., 2016), further
highlighting the importance of duration of exposure in the
process of (mal) adaptation.
Phosphocreatine recovery is decreased by hypoxia in exercise,
which also lowers pH in human gastrocnemius muscle (Haseler
et al., 1999; Hogan et al., 1999). Hypoxia and acid-base
disturbance cause fatigue in skeletal muscle (Stary and Hogan,
1999). Earlier recruitment of diaphragm glycolytic fibers may
be required in hypoxic disease, which should induce, through
activation, an increase in their oxidative capacity. It has been
reported that an additional 5% duration of recruitment increases
myocyte oxidative capacity (Kernell et al., 1987). Also, the
oxidative capacity of limbmuscle is increased by hypoxic training
(Terrados et al., 1990; Abdelmalki et al., 1996; Green et al., 1999).
However, as discussed above, such changes are not observed in
the sustained hypoxic diaphragm. While the above studies use
different metabolic enzymes as a measure of oxidative/glycolytic
capacity, these enzymes may not be maximally active in vivo and
a reserve capacity may exist should more metabolic substrate
present itself. Furthermore, the catalytic activity of an enzyme
under saturating conditions may not change while substrate
flux according to availability and up-stream enzyme activity
in metabolic pathways may be important. We hypothesize
that the metabolic changes described in the sustained hypoxic
diaphragm (Lewis et al., 2016) occur to prevent overloading of the
mitochondrial electron transport chain, subsequent build up and
leak of electrons (which gives rise to ROS) given the decreased
availability of oxygen as the ultimate electron acceptor to dispose
of electrons safely in the formation of water (O2+ 2e− +2H+ =
2H2O), whilst maintaining a focused path of substrate toward the
mitochondria as ATP generation by oxidative phosphorylation is
required for diaphragm function.
Because hypoxia decreases ATP production in skeletal muscle,
tighter constraints in respect of the usage of ATP will be
important, especially in the context of reflex hyperventilation and
diaphragm activation during hypoxia. Skeletal muscle ion pump
ATPases are candidate sites for regulation. The Na+/K+ ATPases
maintain myocyte excitability, regulate myoplasmic volume, and
they play a role in pH maintenance. Increased pump activity
improves skeletal muscle endurance (Clausen, 2003), whereas
inhibition of the pump by ouabain enhances muscle fatigue
(Clausen and Nielsen, 2007). Six weeks of sustained hypoxia
increased Na+/K+ ATPase pump content in rat diaphragm
muscle (McMorrow et al., 2011). Changes in pH regulation may
also be important given that in active muscle in hypoxia, local
acidity is controlled for by the Na+/H+ exchanger removing
protons. Increased Na+/K+ ATPase pump content would be
considered beneficial to diaphragm muscle function albeit at
the expense of requiring more ATP. During muscle relaxation,
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pumps
restore Ca2+ to the sarcoplasmic reticulum from the myoplasm
at the expense of ATP hydrolysis. The areal density of fibers
expressing SERCA2 in rat diaphragm after 6 weeks of sustained
hypoxia exposure was unchanged (McMorrow et al., 2011),
suggesting that calcium handling is unperturbed by sustained
hypoxia in this model, consistent with observations of normal
diaphragm contractile kinetics following sustained hypoxia in rat
(McMorrow et al., 2011) and mouse (Lewis et al., 2016). Myosin
ATPase activity utilizes ATP hydrolysis to move myosin heads
and pull actin filaments, shortening cross-bridges, resulting in
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force generation, regulated by the troponin complex. Significant
decreases in troponin C and troponin I were observed in
mouse diaphragm preparations fatigued ex vivo in acute hypoxia
compared with un-fatigued control, but there is no data yet
concerning the effects of sustained hypoxia. Hypoxaemia in
anesthetized, spontaneously breathing canines induces post-
translational modification of diaphragm troponin I (which could
alter activity, or target for removal to reduce ATP consumption;
Simpson et al., 2000). Alterations at the level of the cross-bridge
may play a role in muscle adaptation to sustained hypoxia from
both metabolic and functional perspectives. Na+/K+ ATPase
and mATPase content are likely candidates for adaptation
during sustained hypoxia. While increases in Na+/K+ ATPase
content are in contrast to required metabolic modifications
(ATP sparing), the observed decreased fiber cross-sectional
areas are suggestive of decreases in mATPase activities, which
would be detrimental to force production but beneficial to ATP
conservation (Lewis, 2014). Further studies are required to assess
the putative contribution of altered mATPases to diaphragm
muscle (dys) function following sustained hypoxia.
HIF-1α is a subunit of the HIF transcription factor complex
that is constitutively expressed and degraded in normoxic
conditions; degradation is prevented under hypoxic conditions.
HIF promotes transcription of the cellular defensive response
to hypoxia by forming a complex with the HIF-1β subunit
and consequent up-regulation of hundreds of genes leading to,
for example, increased erythropoietin (leading to increased red
cell mass), increased glycolytic enzymes which produce ATP
anaerobically, amongst other changes that produce advantageous
adaptations in hypoxia (Semenza et al., 1994; Gao et al., 2004;
Kim et al., 2006). HIF-1α is basally and differentially expressed in
skeletal muscle (Pisani andDechesne, 2005;Mounier et al., 2010),
and is involved in fast fiber type gene expression, whereas the
competing HIF-2α subunit is implicated in driving the slow fiber
phenotype (Rasbach et al., 2010; Lunde et al., 2011; Yuan et al.,
2013). Training in hypoxia induces HIF-1α mRNA transcription
(Vogt et al., 2001). HIF-1α content is increased after 6 weeks
of sustained hypoxia in mouse diaphragm muscle (Lewis et al.,
2016). The role of increased HIF-1α in the hypoxic diaphragm is
difficult to discern given that glycolytic enzyme activities at this
time point are decreased. However, HIF alone is not sufficient to
stimulate expression of several of these enzymes. Nevertheless,
HIF-1α content is increased during sustained hypoxia and likely
to play a role in diaphragm adaptation given potential activation
of hundreds of target genes (Wenger et al., 2005). TheHIF-1:HIF-
2 ratio may also be important in diaphragm muscle adaptation
to hypoxia (Yuan et al., 2013). Of note, G6PD expression
can be regulated by HIF, although this is slower than other
glycolytic enzymes, dependent on redox status, and may not be
activated in sustained hypoxia (Gao et al., 2004; Guo et al., 2009).
LDH and aldolase expression is also HIF-regulated (Semenza
et al., 1996). Other transcriptional regulators may be required
for aldolase and LDH genes, as HIF alone is not sufficient to
drive LDH expression. Of interest, antioxidant supplementation
with tempol (superoxide scavenger) or N-acetylcysteine (NAC)
prevents increased HIF-1α content in the sustained hypoxic
mouse diaphragm (Lewis et al., 2016), highlighting a role
for ROS in HIF stabilization in muscle during sustained
hypoxia.
The diaphragm in sustained hypoxia may adopt a
hypometabolic strategy (i.e., oxygen consumption and ATP
production are reduced after normalizing for size and work), or
there may be increased reliance on fatty acid oxidation and more
focused and controlled routing of substrate to the mitochondria,
a response that differs to that of other muscles, on the basis
of observations from studies of the high altitude pika, COPD
diaphragm, and transcriptional responses of the respiratory
muscles in respect of metabolic substrate utilization, and data
concerning enzyme activity from animal models of sustained
hypoxia (Sheafor, 2003; Wijnhoven et al., 2006b; van Lunteren
et al., 2010; McMorrow et al., 2011; Lewis et al., 2015a, 2016).
Gluconeogenesis is also an option for the diaphragm muscle
in sustained hypoxia given that there is evidence of decreased
fiber cross-sectional areas suggesting protein catabolism, but
metabolic activities of enzymes of the carbohydrate pathway are
also decreased during sustained hypoxia. Enzyme activities of
fatty acid metabolism and downstream reaction products should
be measured in hypoxic respiratory and limb muscles to confirm
their potential role in muscle adaptation (Lewis, 2014).
There is interesting literature in the field of comparative
physiology concerning metabolism in hypoxia-sensitive
and hypoxia-tolerant animals. A two-phase response of
hypoxia-tolerant systems to an oxygen lack has been
proposed (Hochachka et al., 1996) involving balanced
suppression of ATP-demand and ATP-supply pathways to
stabilize adenylate levels, while ATP turnover rates greatly
decline. Translational arrest is one mechanism ensuring
down-regulation of ATP demands. If the period of oxygen
deprivation is extended, rescue mechanisms are initiated by
preferential regulation of the expression of several proteins;
hypoxia-tolerant cells use significant gene-based metabolic
reprogramming strategies. Hypometabolic steady states may
be prerequisite for surviving prolonged hypoxia (Hochachka
et al., 1996). Protein phosphorylation has been identified
as a reversible mechanism for the regulated suppression of
metabolism and thermogenesis during mammalian hibernation.
Phosphatase subfamilies are differentially augmented in the
hibernating squirrel and these augmentations are organ
specific (MacDonald and Storey, 2007). ROS may also be
involved in triggering phosphorylation changes (Wright et al.,
2009).
COULD CALCIUM BE KEY? Ca2+ RELEASE
AND THE SARCOMERE IN THE
DIAPHRAGM MUSCLE FOLLOWING
SUSTAINED HYPOXIA
Given the fundamental role that calcium plays in muscle
physiology and suggestion in the literature of changes in Ca2+
sensitivity of diaphragm muscle fibers in hypoxia and COPD
(Ottenheijm et al., 2005; Degens et al., 2010), some further
discussion of putative calcium-dependent drivers of hypoxic
remodeling is warranted. Ca2+ is released via ryanodine channels
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for muscle contraction. Re-uptake for muscle relaxation is
through the SERCA proteins of the sarcoplasmic reticulum.
Several key intra-sarcoplasmic reticulum proteins signal to
the ion channels in respect of the sarcoplasmic reticulum
[Ca2+], binding Ca2+ to reduce intra-sarcoplasmic reticulum
free [Ca2+]. Critical to contractile function, Ca2+ initiates
myocellular signaling events through Ca2+ binding proteins
such as CaM and calcineurin (Lewis, 2014). It is reported
that hypoxia significantly alters Ca2+ transients in C2C12
myotubes (Kanatous et al., 2009). It is also plausible that
Ca2+-protein interactions may indirectly affect muscle function.
Increased intracellular [Ca2+] increases the expression of
Na+/K+ ATPase α1 mRNA through the calcineurin and CAM
kinase II signaling pathways in rat skeletal muscle oxidative fibers
(Nordsborg et al., 2010). Redox changes to intra-sarcoplasmic
reticulum proteins suggest that ROS could affect Ca2+ signaling
following sustained hypoxia (Lewis et al., 2016). Notwithstanding
observations suggesting that contractile kinetics (and thus
gross calcium handling) are unaffected following sustained
hypoxia (McMorrow et al., 2011; Lewis et al., 2016) there
is limited data concerning Ca2+ dynamics and signaling in
the sustained hypoxic diaphragm and this warrants thorough
investigation.
The sarcomere, the functional unit of contraction, is the
cellular compartment where Ca2+ and ATP combine with
a structure consisting of several regulatory proteins. Since
in our view, disrupted Ca2+ release and re-uptake is not
likely a candidate mechanism underpinning respiratory muscle
dysfunction in hypoxia (McMorrow et al., 2011; Lewis et al.,
2016), the cross-bridge is a likely cellular target, with altered
sensitivity to Ca2+, depleted ATP, and protein degradation likely
contributors to decreased diaphragm force following sustained
hypoxic stress. Indeed, a small change in Ca2+ sensitivity in
sustained hypoxic diaphragm single muscle fibers, potentially
detrimental to function, has been observed (Degens et al.,
2010).
ALL ROADS LEAD TO ROS
We have highlighted structural and metabolic strategies limiting
mitochondrial ROS production in sustained hypoxia. However,
sustained hypoxia induces progressive increases in mouse
diaphragm protein carbonylation and bi-phasic and progressive
protein thiol oxidation concomitant with increased ROS-
sensitive chymotrypsin-like activity of the 20S proteasome and
increased phospho-p38 MAPK content (Lewis et al., 2016)
(which is strongly associated with promoting atrophy (Derbre
et al., 2012; Lemire et al., 2012). Furthermore, hypoxia-induced
increased phospho-p38 MAPK content is dependent on ROS
(Emerling et al., 2005; Lewis et al., 2016). Added to this
the capacity for ROS to induce muscle and mitochondrial
dysfunction and protein degradation, which occur in the
sustained hypoxic diaphragm (Lecker et al., 2004; Shiota et al.,
2004; Moylan and Reid, 2007; Gamboa and Andrade, 2010,
2012; McMorrow et al., 2011; Derbre et al., 2012; Lewis
et al., 2016); the putative role of ROS in COPD diaphragm
dysfunction (Ottenheijm et al., 2006a; Marin-Corral et al., 2009;
Barreiro, 2014); the integral role for ROS in the respiratory
muscle dysfunction following other paradigms of hypoxic stress
(MacFarlane et al., 2009; Yuan et al., 2011, 2013; Semenza and
Prabhakar, 2012; Williams et al., 2015); the fact that increased
contractile activity will also stimulate ROS production (McArdle
et al., 2001; Pattwell et al., 2004; Jackson et al., 2007); that
FIGURE 1 | Proposed actions of reactive oxygen species (ROS) as both advantageous and disadvantageous (and ultimately pivotal) determinants of
diaphragm muscle adaptation to sustained hypoxia. A temporal component impacts all of these processes. Muscle plasticity is determined by complex
interactions between hypoxia/redox stress and three major inter-related processes that are fundamental to muscle performance: contractile activity, metabolism, and
structure/growth/repair.
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ROS are produced by and contribute to damaged mitochondria
(Amicarelli et al., 1999; Hoppeler et al., 2003; Magalhães et al.,
2005; Gamboa and Andrade, 2010; Lewis et al., 2015b, 2016);
and that pathogenesis and/or progression of several models
of respiratory muscle dysfunction, including sepsis, mechanical
ventilation, and muscular dystrophy considered, at least in
part, ROS mediated (Nethery et al., 1999; McClung et al.,
2008; Lawler, 2011), it is entirely plausible that the diaphragm
is manipulated by alterations in redox balance in sustained
hypoxia.
Indeed, a 2D redox proteomics investigation of the mouse
diaphragm following exposure to 6 weeks of sustained hypoxia
clearly shows extensive metabolic enzyme remodeling and
protein carbonylation, with evidence that the stress reached
the cross-bridge, and that many stress response proteins
were affected (Lewis et al., 2016). Similar findings were
observed in an upper airway dilator muscle that contracts
synchronously with the diaphragm (Lewis et al., 2016). Thus,
a respiratory muscle redox fingerprint, indicative of severe
oxidative stress, is detectable following sustained hypoxia.
Chronic supplementation with the antioxidants tempol or N-
acetyl cysteine (NAC) prevented protein oxidation in the mouse
diaphragm muscle following 6 weeks of sustained hypoxia
(Lewis et al., 2016), and importantly, NAC supplementation
prevented sustained hypoxia-induced loss of force- and power-
generating capacity (Lewis et al., 2016). Of interest, tempol,
a membrane permeable superoxide scavenger, did not prevent
sustained hypoxia-induced dysfunction (Lewis et al., 2016),
which led us to conclude that some ROS are required in
skeletal muscle for positive adaptations to sustained hypoxia,
since tempol permeates to the mitochondria scavenging ROS
production at source, whereas NAC is confined to the myoplasm
protecting the cross-bridge apparatus without blockade of
some beneficial redox signaling events e.g., increased HIF-1α
and phospho-p38 MAPK content (Lewis et al., 2016). In the
context of potential interventional therapy for hypoxia-induced
diaphragm dysfunction, a recent article has highlighted the
potential utility of NAC, an FDA approved drug, for COPD
(Matera et al., 2016), which we suggest could be extended
to potentially beneficial effects on respiratory muscle force-
generating capacity.
A conceptual figure detailing the complex interplay of
factors determining redox-dependent respiratory muscle
plasticity in response to sustained hypoxia is shown in
Figure 1.
SUMMARY AND PERSPECTIVES
Sustained hypoxia and increased muscle activity characteristic
of high altitude and various respiratory diseases induce a
complex portfolio of molecular and cellular changes in the
diaphragm muscle which appear to facilitate tissue hypoxia
tolerance (e.g., decreased diffusion distance of O2, decreased
O2 consumption, streamlined metabolic flux, decreased ATP
utilization, and increased cell membrane Na+/K+ ATPase pump
content), but with resultant functional adjustments that are
likely detrimental to the physiological role of the muscle (i.e.,
decreased force- and power-generating capacity). Diaphragm
weakness has implications for respiratory behaviors such as
cough with relevance to altitude and chronic disease states.
Assessment of muscle function ex vivo, comparing normoxic
and chronically hypoxic tissues under “control” conditions, may
bias conclusions favoring deleterious outcomes, and there is an
argument to suggest that hypoxic adaptations should only be
considered in the context of prevailing hypoxia. Understanding
which sustained hypoxia-induced adaptations are beneficial and
which are detrimental to diaphragm muscle function in vivo in
animal models and ultimately in humans at altitude and during
chronic disease states is of utmost importance. The putative role
of sustained hypoxia as a driver of redox remodeling and loss
of power-generating capacity in respiratory muscle of COPD
is currently unknown and constitutes an important gap in our
understanding of the pathophysiology of muscle dysfunction in
COPD. Further studies in translational models building on the
work described herein are required and will potentially provide
an evidence-based platform for antioxidant-based interventional
studies in chronic conditions characterized by hypoxia, such
as high altitude and COPD. NAC may be useful in mitigating
hypoxic-dependent decreases in diaphragm power-generating
capacity without hindering advantageous hypoxia-induced ROS-
dependent cellular adaptations.
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